OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Early Pharmacodynamic Changes Measured Using RNA Sequencing of Peripheral Blood from Patients in a Phase I Study with Mitazalimab, a Potent CD40 Agonistic Monoclonal Antibody
Hampus Andersson, Aastha Sobti, David Gomez Jimenez, et al.
Cells (2023) Vol. 12, Iss. 19, pp. 2365-2365
Open Access | Times Cited: 6
Hampus Andersson, Aastha Sobti, David Gomez Jimenez, et al.
Cells (2023) Vol. 12, Iss. 19, pp. 2365-2365
Open Access | Times Cited: 6
Showing 6 citing articles:
First-in-human phase I trial of the bispecific CD47 inhibitor and CD40 agonist Fc-fusion protein, SL-172154 in patients with platinum-resistant ovarian cancer
Nehal J. Lakhani, Daphne Stewart, Debra L. Richardson, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 1, pp. e010565-e010565
Open Access | Times Cited: 1
Nehal J. Lakhani, Daphne Stewart, Debra L. Richardson, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 1, pp. e010565-e010565
Open Access | Times Cited: 1
Harnessing the potential of CD40 agonism in cancer therapy
Yang Zhou, Ann Richmond, Chi Yan
Cytokine & Growth Factor Reviews (2023) Vol. 75, pp. 40-56
Open Access | Times Cited: 16
Yang Zhou, Ann Richmond, Chi Yan
Cytokine & Growth Factor Reviews (2023) Vol. 75, pp. 40-56
Open Access | Times Cited: 16
Next generation CD40 agonists for cancer immunotherapy
Hampus Andersson, Barnabas Nyesiga, Tova Hermodsson, et al.
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 5, pp. 351-363
Open Access | Times Cited: 4
Hampus Andersson, Barnabas Nyesiga, Tova Hermodsson, et al.
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 5, pp. 351-363
Open Access | Times Cited: 4
Evaluation of a Combinatorial Immunotherapy Regimen That Can Cure Mice Bearing MYCN-Driven High-Risk Neuroblastoma That Resists Current Clinical Therapy
Lauren Zebertavage, Allison Schopf, Megan Nielsen, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 9, pp. 2561-2561
Open Access | Times Cited: 1
Lauren Zebertavage, Allison Schopf, Megan Nielsen, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 9, pp. 2561-2561
Open Access | Times Cited: 1
An Introduction to Recent Approaches Underlying Mechanistic Insights Harboring Oncobiology
R. C. Sobti, Aastha Sobti
(2024), pp. 3-47
Closed Access | Times Cited: 1
R. C. Sobti, Aastha Sobti
(2024), pp. 3-47
Closed Access | Times Cited: 1
An Introduction to Recent Approaches Underlying Mechanistic Insights Harboring Oncobiology
R. C. Sobti, Aastha Sobti
(2023), pp. 1-44
Closed Access
R. C. Sobti, Aastha Sobti
(2023), pp. 1-44
Closed Access
